BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16959616)

  • 21. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases.
    Srodon M; Westra WH
    Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
    Klebe S; Swalling A; Jonavicius L; Henderson DW
    J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and significance of cytoplasmic thyroid transcription factor-1 immunoreactivity.
    Bejarano PA; Mousavi F
    Arch Pathol Lab Med; 2003 Feb; 127(2):193-5. PubMed ID: 12562233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thyroid transcription factor-1 in pulmonary cytology].
    Smojver-Jezek S; Vrabec-Branica B; Juros Z; Boras Z; Cucević B; Mazuranić I
    Acta Med Croatica; 2008 Oct; 62(4):373-8. PubMed ID: 19205414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions.
    Jang KY; Kang MJ; Lee DG; Chung MJ
    Anal Quant Cytol Histol; 2001 Dec; 23(6):400-4. PubMed ID: 11777274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expressions of Thyroid Transcription Factor-1, Napsin A, p40, p63, CK5/6 and Desmocollin-3 in Non-Small Cell Lung Cancer, as Revealed by Imprint Cytology Using a Malinol-Based Cell-Transfer Technique.
    Kawai T; Tominaga S; Hiroi S; Kameda K; Ogata S; Nakashima H; Ozeki Y; Nakanishi K
    Acta Cytol; 2015; 59(6):457-64. PubMed ID: 26696549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Surfactant protein and thyroid transcription factor 1 in pleuro-pulmonary neoplasia. Immunohistochemical study].
    Dessy E; Falleni M; Del Curto B; Braidotti P; Pietra GG
    Pathologica; 2000 Dec; 92(6):496-502. PubMed ID: 11234300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes.
    Roh MS; Hong SH
    J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases].
    Romeike BF; Feiden W
    Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The diagnostic utility of the triple markers Napsin A, TTF-1, and PAX8 in differentiating between primary and metastatic lung carcinomas.
    El-Maqsoud NM; Tawfiek ER; Abdelmeged A; Rahman MF; Moustafa AA
    Tumour Biol; 2016 Mar; 37(3):3123-34. PubMed ID: 26427663
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
    Shield PW; Papadimos DJ; Walsh MD
    Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. WT1, monoclonal CEA, TTF1, and CA125 antibodies in the differential diagnosis of lung, breast, and ovarian adenocarcinomas in serous effusions.
    Zhu W; Michael CW
    Diagn Cytopathol; 2007 Jun; 35(6):370-5. PubMed ID: 17497661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B.
    Kaufmann O; Dietel M
    Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma.
    Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R
    Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thyroid transcription factor 1: a marker for lung adenoarinoma in body cavity fluids.
    Gomez-Fernandez C; Jorda M; Delgado PI; Ganjei-Azar P
    Cancer; 2002 Oct; 96(5):289-93. PubMed ID: 12378596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
    Chang YL; Lee YC; Liao WY; Wu CT
    Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TTF-1 protein expression in pleural malignant mesotheliomas and adenocarcinomas of the lung.
    Di Loreto C; Puglisi F; Di Lauro V; Damante G; Beltrami CA
    Cancer Lett; 1998 Feb; 124(1):73-8. PubMed ID: 9500194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utility of napsin A and thyroid transcription factor 1 in differentiating metastatic pulmonary from non-pulmonary adenocarcinoma in pleural effusion.
    Kim JH; Kim YS; Choi YD; Lee JS; Park CS
    Acta Cytol; 2011; 55(3):266-70. PubMed ID: 21525739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.